GnRH antagonists
- 31 January 2000
- journal article
- editorial
- Published by Elsevier in Fertility and Sterility
- Vol. 73 (1) , 15-17
- https://doi.org/10.1016/s0015-0282(99)00448-3
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study groupHuman Reproduction, 1998
- The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist CetrorelixFertility and Sterility, 1998
- Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulationFertility and Sterility, 1997
- The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer programFertility and Sterility, 1994
- Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulationHuman Reproduction, 1994